drugset / Trial / NCT01276834

Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation

NCT01276834

Phase 4 Terminated 13 enrolled Dianet Dialysis Centers UMC Utrecht · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare in a prospective randomised way the effect of two different immunosuppressive regimens - mTOR-based regimen or CNI-based regimen - on the progression of coronary artery calcification in renal transplant patients measured at baseline, 1, 2, and 3 years after transplantation.

Timeline

Start
2010-09
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule

Indications

No indication recorded.